| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 6mg × 10 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 6mg × 20 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | - | お買物かごに入れる |
| 6mg × 30 tablet | ¥ 9483.61 錠剤 ¥ 316.12 | ¥ 316.12 | - | お買物かごに入れる |
| 6mg × 60 tablet | ¥ 11856.49 錠剤 ¥ 197.61 | ¥ 197.61 | - | お買物かごに入れる |
| 6mg × 90 tablet | ¥ 14229.37 錠剤 ¥ 158.10 | ¥ 158.10 | - | お買物かごに入れる |
| 6mg × 120 tablet | ¥ 15811.29 錠剤 ¥ 131.76 | ¥ 131.76 | - | お買物かごに入れる |
| 6mg × 180 tablet | ¥ 20557.05 錠剤 ¥ 114.21 | ¥ 114.21 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 24mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 24mg × 24 tablet | ¥ 20557.05 錠剤 ¥ 856.54 | ¥ 856.54 | - | お買物かごに入れる |
| 24mg × 36 tablet 無料航空便配送 | ¥ 30048.57 錠剤 ¥ 834.68 | ¥ 834.68 | - | お買物かごに入れる |
| 24mg × 60 tablet 無料航空便配送 | ¥ 47449.69 錠剤 ¥ 790.83 | ¥ 790.83 | - | お買物かごに入れる |
| 24mg × 90 tablet 無料航空便配送 | ¥ 68805.61 錠剤 ¥ 764.51 | ¥ 764.51 | - | お買物かごに入れる |
| 24mg × 120 tablet 無料航空便配送 | ¥ 86997.69 錠剤 ¥ 724.98 | ¥ 724.98 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 30mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 30mg × 24 tablet 無料航空便配送 | ¥ 25302.81 錠剤 ¥ 1054.28 | ¥ 1054.28 | - | お買物かごに入れる |
| 30mg × 36 tablet 無料航空便配送 | ¥ 36376.25 錠剤 ¥ 1010.45 | ¥ 1010.45 | - | お買物かごに入れる |
| 30mg × 60 tablet 無料航空便配送 | ¥ 56941.21 錠剤 ¥ 949.02 | ¥ 949.02 | - | お買物かごに入れる |
| 30mg × 90 tablet 無料航空便配送 | ¥ 79088.09 錠剤 ¥ 878.76 | ¥ 878.76 | - | お買物かごに入れる |
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.